• Explore /
  • Poster
  • / <i>ATM</i> or <i>CHEK2</i> alterations: Potential biomarkers of improved outcomes with irinotecan-containing chemotherapy in advanced pancreatic ductal adenocarcinoma.

ATM or CHEK2 alterations: Potential biomarkers of improved outcomes with irinotecan-containing chemotherapy in advanced pancreatic ductal adenocarcinoma.

Abstract Poster

Authors

null

Maahum Mehdi

Medical College of Wisconsin, Milwaukee, WI;

Maahum Mehdi , Bicky Thapa , Aniko Szabo , Gulrayz Ahmed , Aditya V. Shreenivas , James P. Thomas , Deepika Sriram , Douglas B. Evans , Susan Tsai , Kathleen K. Christians , Beth Erickson , William A. Hall , Thomas McFall , Steve Patrick , Ben George , Razelle Kurzrock , Mandana Kamgar

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 754)

DOI

10.1200/JCO.2023.41.4_suppl.754

Abstract #

754

Poster Bd #

N1

Abstract Disclosures

Similar Posters

First Author: Teresa Macarulla

First Author: Yijiao Chen

First Author: Tian Tian

First Author: Qiuxiang Ou